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CHAPTER ONE
The Problem

Introduction
One task of the health professional is to assure prescribed treat
ments are carried out accurately and consistently by the patient at home.
Literature is rich in data describing the problem of patient non-compli
ance with self-administration of medical modalities (Christensen, 1978,
pp. 171-187).
In "Health Care in the Elderly:

Report of the Technical Group on

Use of Medicaments by the Elderly", The World Health Organization supp
orts the fact that poor foilowthrough in self-administrati on of home
treatment is even more of a problem among the world's aged (1981).
Much speculation and research has been done to explain the pheno
menon of noncompliance and variables that relate to it.

The main causal

themes in literature include lack of motivation, lack of adequate medi
cation education and multiple other differentiating characteristics
(Anderson, 1980, pp. 299-304; Fry, 1981, p. 152; Talkington, 1978, pp.
591-595).

Still others add that inability to follow prescribed regimens

at home is not just one of the causes listed above but generally, a
combination of these factors (Ellor, 1982, p. 330).
Problem Statement
This study explores the problem of patient non-compliance in self
administration of medical treatment in a home setting.
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For numerous
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reasons many patients are unable or unwilling to carry out medical treat
ment as prescribed by their physicians.

One instructional approach used

by health professionals has been proven entirely effective in preparing
and motivating patients to do so.

Study Need
If noncompliance is a multicausal problem, then the solution(s)
should incorporate multiple intervention modalities.

However, few re

search studies reflect an effort to test any one teaching or motivation
al modality, much less the use of several such modalities in one program.
The variety of modalities suggested by other researchers that could be
used include:

patient-responsibility mechanisms, such as contracts;

combinations of individualized and group teaching; repetitive practice;
written, individualized schedules; or role-modeling and use of team
col 1aboration.
There is need for a study that would test a program that incorpor
ates interventions researchers have shown to alleviate but not completely
alter the patterns of noncompliance.

A specialized teaching program

called Self-Administrati on of Medical Modalities (SAMM) has been develop
ed to meet such a need and will be tested in this study.
Study Objectives

The objective of this study is to test the ability of a specialized
teaching program to increase patient medication knowledge and in turn
increase patient compliance in the home over an extended period of time.
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Research Question
The study will explore the problem of patient compliance in spite of
traditional instructions given in a hospital setting.
question asks:

The research

does the use of a program employing multiple individual

ized teaching methods of hospitalized patients make a difference in
patient knowledge and compliance at home on both a short-term and long

term basis?
Theoretical Framework
Systems Theory
The study is couched in Systems Theory which suggests that all parts
of a whole are interdependant.

Each part is complete in its-self yet

necessary to the functioning of a larger unit (Berta!anffy, 1963).

When

a patient presents with a compliance problem regarding his treatment pro
gram, the medical professional is usually faced with not only one causa
tive factor, such as inadequate family support, but many inter-relating
factors such as combination of low motivation, sensory loss and inadequ
ate knowledge level impacting on the patient's decision-making process.
The use of a team approach and multiple teaching modalities takes
into consideration that not just one event or experience of the client
and his support system impacts on his behavior or choices.

Instead, it

considers a variety of interlocking events, decisions, ideas, feelings
and perceptions which culminate in a patient's overt behavior and in what
observers interpret as compliance.
Learninq Theory
Central to the SAMM program is learning theory which suggests con
ditions that must be present for the learner to change behavior.

One is
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learning readiness:

the learner must be ready to accept information

mentally and motivationally (Hallberg, 1976; Pohl, 1978).
Knowledge, frequently the

only aspect addressed in patient teach

ing programs, is a good starting point, and has repeatedly been demon
strated to be a necessary but not sufficient condition for adherence.
The presence of knowledge has failed to be a consistent predictor of com
pliance (Becker, 1979).
After gaining knowledge, the learner still may not alter his methods
of dealing with change if he does not perceive a problem or perceive me
thods suggested as helpful to him (Arakelian, 1980, pp. 25-38; Becker,
1978, pp. 268-277).

Compliance Behavior
Research has identified more than 200 factors associated with com
pliance behaviors (Sackett, 1976) which revolve around four topics:

the

patient, his illness, the regimen and patient-clinician relationship.
The decision to change personal beliefs and initiate actual practice
is the patient's (Becker, 1978, pp, 268-277),

The information, attitudes

and expectations communicated by health professionals should be support
ive of patient motivations and contribute to the treatment process and
the ability to carry it out (Schulman, 1979, pp, 267-284).
Theoretical Assumptions
The following assumptions are made in this study:
1 .

Patients want and seek help in management of their health

problems,
2.

Prescribed therapy is appropriate and essential to recovery or

maintenance of health.
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3.,

Patients need information communicated in understandable terms.

4.

Patient compliance cannot be expected without sufficient in-

formation.
5,

With proper preparation, all members of the health care team are

appropriate educators for patients.
Null Hypothesis

For the purpose of this study the following null hypothesis was con
structed:
Subjects who receive a planned program of instruction on an inpatient
basis will demonstrate no difference in knowledge level and compliance at
home from those who receive traditional instructions or no formal educa
tion. (

=0..05)
Variables

The independent variable is a teaching manipulation by the use of
the S'AMM Program.

The dependent variables are the subject's knowledge

and compliance level at home up to and at six months.
Definition of Terms
Noncompliance
Theoretical:

The subject is considered noncompliant when he does

not carry out his physician's prescribed treatment regimen.
Operational:

As a method of assessing compliance, this study will

measure errors in three ways:
theophylline levels.

patient report, pill counts and blood

A quantification of the subject's medication errors

will be described under section on Interpretation of Compliance Measure
ments and Appendix A.

6

Traditional Patient Instruction
Theoretical:

An informal instruction session to briefly explain

prescribed treatment for the patient's use at home.
given on an inpatient or outpatient basis.

The instruction is

These oral and/or written

instructions usually do not include indepth explanation of reasons for
treatment or possible side-effects.

They are usually given shortly be

fore the patient leaves the hospital or clinic.

Traditional patient in

struction usually does not include self-practice by the client, especial
ly on a repetitive basis.
Operational:

A patient instruction program as usually performed;

does not include the SAMM program format.
ireatment Approach
Self-Administrati on of Medical
Modalities
The Self-Administration of Medical Modalities (SAMM) Program is a
teaching approach that recognizes the individuality of each person, dif
ferences in cognitive styles, and perceptual and expressive differences.
It is defined as a formalized patient education program employed by the
Pulmonary Rehabilitation Team at Loma Linda University Medical Center
(1982).

Its design to involve patients in their own care includes a

variety of modalities to facilitate patient responsibility, raise patient
knowledge level, and to provide collaboration between team members.

Those

modalities are described in the section on methodology.
Learning Levels.

Three graduated learning levels are used and

criteria for moving from one to the next depends on patient competency.
The levels are as follows:

7

Level I - The subject receives instruction regarding actions and
potential side-effects of medications.
staff.

Medications are administered by

When designated staff determines the subject has safely demon

strated use and knowledge of medication at this level, the subject will
be progressed to Level II.

This is determined by the completion of

specific tasks for each level as shown on the SAMM Program Level Progress
ion Checklist (Appendix B).

Any level can take from 24 hours to several

days to complete.
Level II - The subject assumes responsibility for self-administra
tion of medications.

The subject comes to the nursing station not later

or earlier than 15 minutes of the prescribed time with only minimal
assist and monitoring by staff and takes the medication, answering staff
regarding the action and possible side effects of the medication.
subject maintains a record of medication administration.

The

The staff will

monitor this record and correct or reinforce any needed data correction.
When designated staff determines demonstrated use and knowledge of
medication at this level, the subject will be progressed to Level III.
Level III - The subject will

self-administer prescribed medications

at the bedside in accordance with the home medication schedule and record
it.

The staff will be available for assistance upon the subject's request

but will not initiate and/or participate in administration of medications.
The designated staff member will check the subject's record every shift,
noring appropriateness and accuracy of use.

This will be ascertained by

counting the remaining medications and comparing that number against what
the subject records as taken and was originally

dispensed.

Theophylline

levels will be determined and observed for discrepancies in the record
(see Interpretation of Compliance Measurements and Appendix A).
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When successfully progressed through all three levels, the subject
will be recommended to the attending physician as sufficiently prepared
for discharge.
Proficiency Levels.

Proficiency areas specified on the Levels Check

list (Appendix B) include:
1 .

knowledge of action and use of medication

2.

knowledge of major possible side-effects

3,

actual performance of use and storage of medications

4,

and any problem-solving situation.

The use of reinforcement and repeated practice is generously used.
The program is individualized
for.

For example:

so

that sensory deficits are compensated

provision of brailie-marked medication boxes for the

blind, easy to open pill bottles for arthritic or weak hands and large
lettered print on medication schedules for impaired vision.
Methods/Content for Patient
Education
Content of the educational

program includes reasons for and use of

prescribed treatments, medication side effects and problem-solving tech
niques.

Both individualized and group dynamics are used as well as formal

and informal teaching methods in the classroom and at the bedside.

Three

graduated learning levels are used and criteria for moving from one to
the next depends on patient competency.
Methods to Facilitate Patient
Res ponsibi1ity
Formal, written patient contracts are used in the program outlining
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program goals (Appendix C).

Individualized educational objectives are

informally worked out with patient and discussed in a formal team con
ference .

Summary
Literature indicates there are multi causal problems with follow
through by patients in management of their medications at home.

If

patients want help in management of their health problems but need know
ledge communicated in an understandable way to follow through, then a
patient education program tailored to the patient's individual needs
can make a difference in his compliance.

CHAPTER TWO
Review of Literature

Introduction
A review of the literature about patient compliance with prescribed
medical regimens reveals that compliance is related to knowledge level.
Increasing knowledge levels is discussed with learning theory.
Self-care concepts central to the SAMM program are discussed in the
literature and stress patient responsibility and contracting for self-

care.
Related Articles on Compliance
A variety of researchers have studied the frequency of non-compliance
in many populations and its possible causes.

Aging and inadequate know

ledge levels are frequently recurring companions of non-compliance.

Frequency of Noncompliance
Literature reveals that 20 - 50% of patients do not comply with pres
cribed therapeutic regimens (Christensen, 1978, pp. 171-187; Connelly,
1978, pp. 15-18; Marston, 1970, pp. 312-323; Mitchell, 1974, pp. 75-87).
Christensen points out that this noncompliance occurs in all ages, disease
states, and socioeconomic backgrounds (1978, p. 171).
Major findings regarding treatment noncompliance point towards lack
of patient motivaton, his health beliefs, and inadequate knowledge base
(Bille, 1977, pp. 55-57; Dali, 1982, pp. 283-290; Fry, 1981, p. 152;

10
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Kasl , 1966, p. 266; Kennedy, 1981, p. 37; Kinsman, 1980, p. 107;
Schwartz, 1975, p. 1810; Talkington, 1978, pp. 591-595; Webb, 1980,
pp. 1047-1055; World Health Organization report on drugs, 1981, p. 279).
Other factors cited as significant indicate that the greater the
number and frequency of medications prescribed, the greater the noncom
pliance; the greater the degree

of communication and interaction with

the appropriate health professional, particular!*ly the physician; the
greater the cost, educational level, family support and sensory deficits
hearing and sight, the higher the chances for compliance variations (Beck,
1980, p. 1097; Brand, 1977, p. 78; Dali, 1982, p. 290; Ellor, 1982, p. 330;
Fletcher, 1979, p. 189; Kinsman, 1980, p. 107; Morel!, 1981, p. 731; Shulman, 1982, pp. 24-27; Talkington, 1978, p. 595),
Many authors concede that the reasons for noncompliance are most
likely a combination of the above factors, that is, the problem of noncompliance is multicausal (Ellor, 1982, p. 330; World Health Organization
report on drugs, 1981, p. 280).
Knowledge and Compliance
Knowledge level is associated with noncompliance.

Although research

does not support the idea that raising an individual's knowledge-level
will ensure proper follow through in taking the medication (Beck, 1980,
pp. 1094-1097; Bille, 1977, pp, 55-62), it does attest to the fact that
compliance cannot occur if the client/patient does not understand what
he is to do (Milazzo, 1980, p. 1081).

Therefore they stress programs

that are educative in nature to allow the patient the choice of compli
ance (Christensen, 1978, pp. 171-187),
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Raising Patient Knowledge
A variety of studies have demonstrated that patient knowledge can
be raised by educational programs (Linde, 1979, pp. 282-286; Milazzo,
1980, pp. 1079-1082; Sechrist, 1979, pp. 51-58).

However little research

has explored specific methods for raising that knowledge level.

Studies

that have been done included education techniques such as formal versus
informal teaching (Bille, 1977, pp. 60-62; Milazzo, 1980, pp. 1079-1082)
repetitive/individualized learning (O'A! troy, 1978, pp. 131-136; Hecht,
1974, pp. 113-129; Sechrist, 1979, pp. 51-58), Master's prepared versus
"floor nurse" instructors (Linde, 1979, pp. 282-286), more than one
teaching modality (Levine, 1979, pp. 1700-1703), behavioral patterning,
role modeling, and counseling (Anderson, 1982, pp. 1673-1675; Cockerman,
1980, pp. 164-172; Talkington, 1978, pp. 591-595).
Theories on Learning
Learning theories indicate that specific conditions must be present
for the learner:

(1) motivation and physical/mental readiness, (2) ability

to perceive his environment and meaningfulness in the material/activities,
(3) some type of conditioning stimulus with repetition, trial and error
experiences, all based on previous knowledge and experience and (4) imi
tation and satisfactory reinforcers (Hallburg, 1975, pp. 13-14; Pohl ,

1978, pp. 6-27).
Assessing learner readiness is stressed by Shaw as the first step to
wards successful teaching (1981, p. 238).

Knowledge of a patient's edu-

cational status and perception of his needs would begin to fulfill the
first learning conditions and serve as an on-going assessment of the
person's continuing readiness for further Teaming.
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Gagne lists a variety of learning activities:

(1) association,

(2) trial and error, (3) conditioned-response, (4) verbal association and
(5) insight.

However, he states one must look for the capabilities of

the learner and the situation outside the learner and tailor the learn
ing experience to where the learner is at that point.

He stresses that

there is no "one way" (1965, pp. 8-20).
Patient Self-Help Considerations
Just as important as the patient's motivational preparation is his
subsequent assumption of active responsibility for his own health care.
Preparing the patient through knowledge and motivation must be followed
by promotion of self-reliance.

Self-responsibility, or self-help can be

encouraged through collaborative team interactions with the patient and
behavioral agreements.
Theories on Self-Help
Beckner advocates the use of self-reliance and individual responsi
bility for health maintenance and health care learning (1978, pp. 268-277).
Studies on hypertension stress the need for col 1aborative-type interactions
between patient ahd health professionals to encourage self-responsibility
(Shulman, 1979, pp. 67-384).

Shulman feels, however, that certain pre

existing conditions must occur prior to what he calls "active patient
orientation".

These include:

(1) attitudes and expectations communicat

ed by health professionals that are supportive to patient's motivations
and abilities, (2) a collaborative treatment process between the patient
and health professional, involving two-way communication and joint decision
making, and (3) medical resources provided in a way to insure usefulness
to the patient (1979, p. 267).
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Contracts as Behavioral Agreements
Verbal and written contractual agreements are suggested as a method
of clarifying patient/health professional needs and goals and assuring
committment on both sides and movement toward specific behavioral object
ives (Becker, 1978, pp. 57-59; Levy, 1979, pp. 281-284; Rosen, 1978, pp.
410-415).

effort:

Rosen outlines the components necessary for this agreement of
(1) selection of treatment goals, (2) setting of time limits,

(3) selection of treatment methods and personnel, and (4) definition of
the patient's role.

In the case of a written agreement, this process is

concluded with signatures (1978, pp. 410-411).
Discussion of Similar Studies
Many studies have described the problems and causes with patient
self-administration of medical modalities.

Few research studies reflect

efforts to test tools for facilitating patient knowledge and compliance.
Formal and Informal Teaching
Formal versus informal teaching format was compared in a pre- and
post-test intervention study in two metropolitan Milwaukee hospitals.
The purpose was to investigate the possible relationship between know
ledge of disease and compliance with post-hospital prescriptions.

A

sample of 24 subjects were divided into two equal groups treated to
either a teaching program of structured information or a program of the
hospital's existing informal teaching methods.

Findings suggested a

nearly equal amount of learning by both methods of teaching and that
compliance was not significantly related to the patient's knowledge of
his disease entity (Bille, 1977, pp. 55-62),
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Another study to determine the effects of formal teaching on pat
ient's knowledge level of his medication management was designed as an
experimental, three group, before-and-after design.

The setting was a

large urban teaching hospital; the sample, 25 patients.
was on a one-to-one basis.

The teaching

The test was administered prior to discharge

(Milazzo, 1980, pp. 1079-1082),

The study used a control group to assess

for test-wiseness and depended more on an objective knowledge test.

They

reported the subjects receiving formal teaching exhibited greater know
ledge than those receiving informal teaching.
Repetition/Graduated Learning
Repetition was the theme of a study done in an inpatient and outpa
tient department in a large university teaching hospital and a smaller
state hospital in a large city outside the USA.

A post-test only con

trol group design was used where the control group of 41 was treated only
once (Sechrist, 1979, pp, 51-58).

The hypothesis was supported and stated

that repetitive teaching regarding use of drugs to be taken at home will
increase adult patient's knowledge when compared to single event teaching.
No attempt was made to determine the relationship to long-term memory or
compliance,
Hecht studied 47 adult tuberculosis subjects attending an outpatient
chest clinic and demonstrated that reinforcing one-on-one conversations
with clinic nurses regarding directions for administration of medications
resulted in a large increase in the accuracy of medication administration
at home.

The study used a comprehensive method of measuring compliance

through two home visits in order to interview the subjects, check urine
medication levels, and do a pill count (Hecht, 1974, pp, 113-129),

16
One study involving reinforcement took its subjects through a threestep educational program and graduated subjects according to their level
of accomplishment and self-responsibility.

The sample of 76 inpatients

received formal lessons, written drug infomation, and one-on-one teach
ing.

It included assuring patient readiness for learning and opportunity

for problem-solving.

Results showed an increase in patient knowledge

and compliance, especially for internally oriented, self-reliant patients.
However, after one month, patients forgot most of what they had learned
(D'Altroy, 1978, pp„ 131-136),
Using More Than One Teaching
Modality
The idea that a multi causal problem such as noncompliance requires
multimodality solutions has been strongly emphasized,

A study of 400

hypertensive subjects attempted to evaluate the effects of one or more
therapeutic interventions on patient compliance with prescribed medical
treatment (Levine, 1379, pp. 1700-1703).

After a formal education pro

gram, additional treatment interventions included one or a combination
of the following:

an exit interview, family support and/or all three

modalities but significantly more with a combination of two or more
treatment modalities.

Long-term compliance lasting up to 18 months

after starting the study was reported.

Other studies have not shown

this compliance.
Collaborative Effects
One last study illustrates the impact of collaborative efforts be
tween subject and a health professional and compliance.

Study treatment
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included interactions that educated the subject regardi ng specific
medical problems, medication regimen and outcomes expected.

It was based

on good rapport and free communication between patient and physician.
Patient participation was an intergral part of the experimental group.
The study consisted of 182 experimental and 156 control subjects from a
family practice clinic and a nearby comprehensive health care clinic.
Four compliance catagories were formed:
ment and behavioral changes.

medication, appointments, treat

The weakness of the study was that compli

ance was determined by subjects' reporting by telephone two weeks follow
ing the clinic visit.

Compliance rates were higher in each category for

the experimental group (Talkington, 1978).
Summary
Chapter two has presented the area of noncompliance as discussed in
the literature.

The literature review revealed that much effort has gene

into describing the problem with less effort in testing structured learn
ing formats to increase compliance.

Theories in learning and self-help

were discussed.
Many programs and studies were planned with the goals of knowledge
and compliance which have utilized a variety of methods,

They include:

value of one-on-one teaching in addition to group; formal and informal
teaching; repetitive teaching; team collaboration; use of more than one
modality; increasing patient knowledge; tailoring teaching approach to
the individual's health locus of control; and patient responsiblity
including behavioral agreements.

CHAPTER THREE
Study Methodology

Introduction
This chapter describes the methodology of this study.

It details

the projected design which incorporates a selected population and desig
nated setting.

It will specify what instruments will be used, how data

will be collected, and under what protection to the participant.

Data

analysis used for its methodology are concluded with the limitations of
the design.
The main question relates to the effectiveness of the Self-Admini
stration of Medical Modalities model (SAMM) in raising knowledge levels
and resulting in improving medication compliance.
Design
This study is a quasi-experimental longitudinal design with convenience sampling,

Pre- and post-testing is to determine increase in know-

ledge impacting on compliance over a period of 6 months.
Samplinq
A convenience sampling of 120 subjects
a six month period will be selected.

admitted to the study over

Patients will be selected as they

are admitted to one of two inpatient units.

Criteria for admission to

the study are described in Appendix D, and include a diagnosis of Chronic
Obstructive Pulmonary Disease (COPD), documentation of medication admini
stration needs willingness to sign a SAMM Program contract, absence of
18

19
rehabilitation in the past two years, and 46-75 years of age.

Patients

meeting these criteria will be invited to participate in the study.
Assignments to the experimental group (Group A) are made as a matter

of convenience.

Group A includes those admitted to the pulmonary medi-

cal unit where the staff is familiar with the SAMM program,

The control

group (Group B) are those subjects accepted into the study who are ad
mitted to the general medical unit and who will receive traditional
teaching.
Setting
The setting of the study is two medical units in a tertiary, acute
care, selected, 500 bed, private, suburban hospital in Southern Calif
ornia and in the subjects' homes.
Protection of Rights
Admission to the study will be voluntary,

Patients will be ap-

preached for participation by this investigator upon recommendation of
team members.
The purpose of the research, subject protection and potential ben
efits of participation will be explained to the prospective subject.
Each subject will sign a consent to participate in the study (Appendix E
for Group A, and Appendix F for Group B).

Permission to conduct the

study will be obtained from nursing administration from those private
physicians whose patients will be included and from appropriate hospital
staff.

The research proposal will be submitted for approval to the Re

search. in Nursing Committee a subcommittee of the Institutional Review
Baord.

Only after permission is obtained will data collection occur.

Subjects will be referenced by consecutive numbering rather than by name.
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Financial support for the study to purchase theophylline prescrip
tions will be supplied by the pharmaceutical company sponsoring this
study.
Procedure for Data Collection
Data will be collected upon hospital admission, at hospital dis
charge and every month for 6 months during home visits to ascertain
subject knowledge level and compliance (Appendix E)»
Hospital Admission

Upon admission to the hospital, demographic and medical baseline
data will be collected from the patient’s medical record and during
patient interview using the Initial Assessment Form (Appendix H).

Upon

fulfilling the criteria for admission to the program (Appendix D), the
subject will be assigned to Group A or B as specified in the samping
procedure.
Subjects will then be administered the knowledge test (Appendix K) to
assess understanding of medication administration.

In order to assure

appropriate dosage and adequate bronchodi1ation, the subject will be re
gulated on theophylline pills (Theodur) to maintain blood theophylline
levels between 10-20 ug/ml.

The SAMM Program treatment will be given to

Group A and traditional or no teaching to Group B,
Hospital Discharge

The day of hospital discharge the subject will be assessed again for
further demographic and medical data (Appendix I).

The knowledge test

will again be administered to assess change in knowledge level since
admission.

The subject will be given a prescribed number of pills (100)
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of the same theophylline preparation used throughout his hospitalization.
He will be instructed to return any pills he does not use with the excuse
of conserving money.

He will not be informed that his pills are being

counted.
Monthly Home Visits
Each subject will be interviewed in his home on a monthly basis by
a research assistant who is a Home Care Respiratory Therapist (Appendix J).
The investigator who interviewed the patient in the hospital or who teach
es medication principles will not be the same investigator who visits in
the home.

This is to prevent subjects associating the teaching program

with the home visitor, and is an attempt to avoid the Hawthorne effect.
During the monthly visit by the Home Care Respiratory Therapist, any
remaining pills will be collected and the patient will be given a fresh
supply of 100 tablets.

A blood theophylline level will be drawn by the

therapist at 3 and 6 months.
The therapist will then ask the following questions:
1.

How frequently have you been taking your Theodur?

2.

At what dosage have you been taking it?

3.

Have you missed any doses?

4.

If so, approximately how many have you missed over an average

week?

5.

Do you feel you have been able to take your medication as pres

cribed?
6.

If not, why not?

The old pills will be returned to the researcher who will document
the number of pills remaining, subtract the total number prescribed to
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ascertain the number of pills expected to be remaining out of 100 tablets.

The therapist then notes any discrepancy between the pill count

and the subject's report of medication usage,

The subject will not be

informed the pills are being counted nor when the therapist will visit.
Blood theophylline levels will be compared with the subject's reporting
of pill consumption and compared for cons is fancy with the level expected
at a given dosage of oral theophylline (Appendix A).
Interpretation of Compliance

Measurements
The Performance Index is designed as a means of quantifying subject
compliance or medication performance, based on pill count data.

The Re

liability Factor is to measure how accurately patients report errors com
pared to the actual pill count.

Some studies suggest the interview

method of testing compliance with medication taking is not necessarily
as valid as others, as many times subjects do not report accurately
(Kinsman, 1980, pp. 97-107; Roth, 1978, pp. 361-370).

For this reason,

a blood theophylline level is also compared with the pill count, with the
subject's reporting at discharge, and at 3 and 6 month intervals post
discharge.
Any errors in the pill count are compared against the subject’s re
port of error and given a score according to the scale in Appendix A.
If the subject's Reliability Factor (subject's report of error) agrees
with the subject's Performance Index (the actual pill count) and is below
4 on each scale, and the theophylline level falls between 10-20 ug/ml,
the subject will be considered compliant and not making any serious
medication errors..
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If the subject's Performance Index is greater than 3, the Reliability
Factor is less than 4 and the theophylline level between 10-20 ug/ml,
compliance will be questioned and the subject reinstructed in proper
dosage administration,

If this inconsistancy continues, it will be con-

sidered noncompliance.
If the Performance Index is greater than 3 and the Reliability Factor
less than 4 and the theophylline level is less than 10 or greater than
20 ug/ml, a need for dosage adjustment will be considered,

Blood theo-

phylline levels that are too high or too low and not obviously due to
improper administration, may indicate improper oral theophylline dosage
and contribute to noncompliance.
As data is analysed, subjects making serious errors (error more than
15% on the pill count) will also be examined separately as a matter of
interest and not considered to support the null hypothesis.
Instrumentation
The Pulmonary Medication Knowledge Test will be administered upon
admission to the study to measure the subject's level of medication under
standing prior to the teaching program.

The same test will be given upon

discharge from the SAMM Program and the hospital to determine his in
creased level of knowledge on the day of discharge.

The test is administ

ered again at three and six months after discharge in the subject's home,
to assess, retention of knowledge (Appendix F).
Because no standardized knowledge test is available for COPD patients
in the SAMM Program, a test has been designed and consists of ten multiple
choice questions and ten true-false qustions covering relevant points
from major content areas of the teaching program.

These areas include:
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action of an oral bronchodi1ator; adverse effects; time and dosage
management; scheduling; and problem-solving skills.
Instrument Validity

Content and face validity have been accomplished through a team of
pulmonary staff members who have judged that the items do reflect congruity between what is actually included and what would be included (Dempsey,
p. and Dempsey, A., 1981, pp. 69-70; Green, 1975, pp. 138-143),
Instrument Reliability
CORD patients outside the study but fitting its criteria will be
administered the knowledge test to ascertain reliability.

The split-half

method will be then used with the Spearman-Brown formula (rxx=

2roe -) to

1+roe

correlate subjects' scores on even number test items against scores on
odd-numbered items (Green, 1975, pp. 146-147).
Item analysis will be conducted on these trial test scores and the
difficulty value obtained.

The Kuder-Richardson formula (rxx

1

will be used for calculating internal consistency (Green, 1975, p. 147).
Post-test Wiseness
One of the major problems with test-retest method of evaluation is
realistically deciding how long a time interval between the two tests
should be.

If the interval is too short individuals tend to remember

their responses to the items on the first administration.

To reduce the

possiblity of subjects becoming test-wise, even numbered items from the
knowledge test will be administered on the day of admission to the study
and at 3 months post discharge.

Odd numbered items will be administered

on the day of hospital discharge and at 6 months post discharge.
and Dempsey, 1981, p. 72; Green, 1981, p. 146).

(Dempsey
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Data Analysis

The acceptance or rejection of the null hypothesis will depend upon
the significant differences occuring in each subject's knowledge level
between admission and discharge> and at three month and six month inter
vals after discharge; and the compliance level as determined by signi
ficant variations between Performance Indexes computed at monthly inter
vals post dischargeThese statistics will then be compared between Groups A and B at
each interval in knowledge level and compliance.
Descriptive Data
Descriptive statistics will be presented in table form with the per
cent of subject error as shown by a pill count error greater than one or
by inappropriate theophylline level.

This table will also show the per

cent of subjects making serious errors (more than 15%) or theophylline
levels not within appropriate range.

A second table will show the mean

scores and standard deviations of each group computed from the scores on
the knowledge test and the monthly Performance Index, Reliability Factor,
and theophylline levels.
Inferential Statistics
Inferential statistics will be used to determine if the differences
noted between groups A and B are statistically significant and whether
they are dependent on the SAMM treatment.

They will be used to determine

whether the hypothesis will or will not be accepted.

Using parametric

tests, a level of statistical significance will be set at ^ =0.05 for all
analysis,
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Tables to delineate data generated by t-tests (t=-^~—) and ANOVA
-2
nsy
■) will include a comparison of individual group mean scores
(F=
S2pd

longitudinally within each group and horizonally between Group A and
Group B mean scores.

Categories will include:

knowledge test means

between and among Groups A and B; Performance Index between and among
Groups A and B; Reliability Factor between and among Groups A and B;
comparisons between Performance Index and Knowledge Test mean scores of
both the experimental groups and comparison between the performance and
reliability of the experimental and control groups.
Methodological Assumptions
It is assumed that:

(1) subjects will accurately report medication

useage, (2) the pill count will accurately reflect patient compliance,
(3) the knowledge test measures accurately subjects' understanding about
medication and (4) that subjects are interested and perform at their
maximum capacity.
Limitations of Study
Due to the small sample size, limited age range and the exclusive
ness of a rehabilitation population, the results from this study will not
be generalizable to any other population.

However, it will demonstrate

the effectiveness of the SAMM program in this population.
Data collection is dependant on the subject's accurate reporting of
pills used and on his saving unused medication.

However, Hecht has re

ported that although a patient reporting alone may have questionable
reliability, pill counts in addition to verbal report can raise one's
confidence in the accuracy of predicting compliance (1974, pp. 113-129).
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Summary
This study is to test the ability of SAMM, a specialized inpatient
teaching program to increase a subject's medication knowledge and compli
ance in a home setting.
This study uses an experimental pre- and post-test control group.
Data will be analysed to assess significant change in each subject's
knowledge level from admission pre-testing to post-testing on discharge
and at three and six month intervals.

It will also be analysed to assess

change in each subject’s compliance in pill taking as compared on dis
charge to monthly home visits.

Data will also be analysed to determine

significant differences between knowledge and compliance levels between
Group A and Group B.
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Performance Index and Reliability Factor
Adapted from
Hecht (1974, p. 119)
PERFORMANCE INDEX
Pill Count Performance
No error, or one
pill in error
One pill to 4%
error
5-9% error
10-19% error
20% error or more

Performance Index

0
2
3
4
5

RELIABILITY FACTOR
Patient Performance
No error, single pill
error, or any reported
error

Reliability Factor

0

Pill count error less
than 5%, denied
5-10% error, denied
11-15% error, denied
16-20% error, denied
21-25% error, denied
26-30% error, denied
31-35% error, denied
36-40% error, denied
Greater than 40% error,
denied

10

Plus 5 for each theophyllin
level below 10 or above
20 ug/ml for maximum of

10

2
3
4
5
6
7
8
9

Appendix B
SAMM Program
Level Progression Checklist
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Date Entered Program

DATE

SIGNATURE

DATE

SIGNATURE

DATE

SIGNATURE

DATE

SIGNATURE

Date Completed Level I
Date Completed Level II
Date Completed Level III
PATIENT OBJECTIVES
(Patient will be able to:)

LEVEL I

LEVEL II

State names of medications correctly & know where to find
1. the correct bottle. Can identify medication by color, shape,
size, etc.
2

State the correct dosages and times to take
the medications/treatments.
State the possible side effects or know where

3. to find this information.

4. Know what actions to take when side effects occur.
5.
R

State special instructions relevant to treatment
program (e.g., take with antacids, avoid milk, rinse
mouth after treatment, avoid after major meals, etc.)
State reason/purpose for taking medications/
treatments & importance of following regimen.
Understand howto adjust medications/ treatments (e.g.,

7. starting, discontinuing, following a tapering schedule, etc.)
Understand consequences of no use or improper use

8. of medications/treatments.

9.

Understand principles of & need for decontaminating
equipment.

'

Take medication/treatment as provided by
nurse/therapist.

111. Seek nurse/therapist when medication/treatment is due.
Choose correct medication to be taken at appropriate
12. time and explain why this is necessary.
13. Choose correct positions for specific lobe of
lung to be drained.
14.

Demonstrate ability to disassemble and reassemble
breathing manifold, and attach to breathing machine.

■tc Demonstrate correctly the ability to manually
'3‘ percuss and vibrate.
16. Demonstrate ability to clean equipment.
17. Seek help when equipment is malfunctioning.
18. Develop medication schedule to be implemented at home.
1 q Use schedule to take medications/ treatments
S' correctly and at the right time.
Verbalize understanding of need to refill appropriate

20. prescriptions before the medications run out.

Lama Linda University Medical Center

Seif-Administration of Medical Modalities
Progression Checklist
23-1129 (8-82)

I PATIENT IDENTIFICATION

LEVEL III

Appendix C
SAMM Program Agreement
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SAMM PROGRAM AGREEMENT
Loma Linda University Medical Center

Upon entering in the Self-administration of Medical Modalities (SAMM) Program,
I will be evaluated by the comprehensive pulmonary care team. An individualized
program will be recommended for me. I will then be educated and supervised in regards
to my treatments and medication. The objective of the SAMM Program is to provide me
with an opportunity to learn about my health care. I, along with the various team
members, will be setting goals for my competent self-administration of treatments and
medications. We will set up a schedule together and will institute this schedule here
at LLUMC as I will be using it at home. This may help me to develop my skills for
becoming as independent as possible.
After discussing this matter with a pulmonary rehabilitation team member and
reading this summary, I understand the nature of this program and agree to participate.

SAMM PROGRAM CANDIDATE

PULMONARY REHABILITATION TEAM MEMBER

DATE

23-1134 (8-821

Appendix D
Criteria for Admission to a SAMM
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Criteria for Admission to a SAMM Program
The prospective subject demonstrates:
1.

Symptomatic pulmonary disease but has a room air
P02 greater than 60 mm/Hg

2.

Ability to read, speak, write and comprehend
English

3.

Willingness to participate

4.

No underlying disease that would interfere with
teaching (e.g,, organic brain syndrome, psychosis,
unrehabilitated substance abuse).

5.

Alertness, orientation and potential for mentally
and physically assuming responsibility for his
activities of daily living

6.

No SAMM Program in the past three years

7.

Age between 46-75 years of age

8.

Medical stability (e.g., controlled arrhythmias/
failure, no evidence of acute MI within preceeding six months)

9.

Adequate financial resources and is within
traveling distance for Home Care Therapists

10.

Followup by LLUMC physician

11 .

No use of medication listed as a controlled sub
stance in the Federal Act and Regulations, ex
cluding medications designated under Article I,
Section 5.4, but including all other narcotics,
hypnotics and tranqui1izers

Appendix E
Scheme for Pre- and
Post-testing of Groups A and B
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Scheme for Pre- and Post-testing of Groups A and B

Group

Intervals

Experimental A

Pre
KDSb

Control B

KDSb

Key:

SAMM
X

Post
KSa
KSa

Imo
CSa

2mo
CSa

CSa

CSa

3mo
KDSCa

4mo
CSa

5mo
CSa

KDSCa

CSa

CSa

6mo
KDSCa

KDSb

- Knowledge test, demographic data collection before
manipulation of independent variables

X

- Experimental manipulation of independent variable
(SAMM)

KSa

- Knowledge test after manipulation of independent
variable

CSa

- Compliance testing after manipulation of indepen
dent variable

KDSCa

- Knowledge test, demographic data and compliance
(pill counts, theophylline level and self report)
testing after manipulation of independent variable

KDSCa

Schedule of Data Collection:
Demographic and Medical Data

Admission
to Study _

Age
Diagnosis
Name of Physician
Language
Previous SAMM Program
Source of Income
Related Medical Problems
Further Medical Problems
Medications
Orientation Level

Day of Hosp
Discharge

Monthly

3 & 6 mo
Intervals

X
X
X
X
X
X
X
X
X
X

X
X
X

X

Pill counts
Theophylline levels
Patient Self-report of pill Consumption

X
X
X

X

X
X
X

Knowledge Test

x

X
X

Compliance Checks Data

X

X

y

Appendix F
SAMM Program Study Consent Form
(Experimental Group)
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LOMA LINDA UNIVERSITY MEDICAL CENTER
S.A.M.M, Program Study
Consent Form
I am willing to participate in a study to be conducted at the Loma Linda
University Medical Center.
I have been told that:
1.

the study is designed to help health care personnel understand
the effect of a medication teaching program called SAMM and that
it will involve my learning how to take my own medications and
practice using them while supervised in the hospital.

2.

during the course of the study, I will be expected to undergo
periodic testing to check my knowledge, attitudes and health
behavior related to my illness.

3.

a respiratory home care therapist will visit my home monthly
for 6 months to administer these tests.

4.

I will be informed of change in the nature of the study or in
the procedures described above.

5.

the study involves no financial cost to me. There may be a
potential risk of fatigue as a result of taking written tests
that measure my knowledge and health behaviors. I have been
told that these tests will have general and personal questions.

6,

among the potential benefits that have been described to me are
the possibility of gaining greater knowledge about my disease
and medications and learning more individualized ways of coping
with them. I will also receive a free supply of any oral
Theodur prescribed for me during the length of the study.

7,

because of the experimental nature of this study, it is possible
that these benefits may not occur.

8.

trained personnel will be available at all times during classes
and testing so that any questions I may have shall receive atten
tion. I further understand that if at any time in this study it
is determined that my assigned medication program is found to be
less beneficial than another, I will be promptly notified.

9.

refusal to participate in this study will involve no penalties
or loss of benefits to which I am entitled. I have been told
that the information obtained in this study is confidential
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and that my name and identity will not be disclosed without my
consent in any published document.
10.

that my participation in this study is voluntary and I may
leave the study at any time unconditionally and without pre
judice to my continued care.

11.

in the event of difficulties as a result of participation in
the research program, I may contact Glenn Sharman, Patient
Representative at (714) 824-0800, extension 4634, for informati on.

I have read the contents of this consent form and have listened to the
verbal explanation of the investigator. My questions concerning this
study have been answered to my satisfaction. I may call Elizabeth Maddox,
RN, researcher, at the Pulmonary Rehabilitation Department (714) 824-4495
if I have additional questions or concern about my participation in this
study. I have been given a copy of this consent form.

Signature of Subject

Date

Witness

I have reviewed the contents of this form with the person signing above.
I have explained potential risks and benefits of the study, as described
above.

Investigator

Dace

For all inpatient studies, to insure that patients receive coordinated
care from the investigator and the primary physician or rehabilitation
team, the primary physician or rehabilitation team coordinator must sign
this form as indicating he/she has knowledge of this research study.

Signature of Primary Physician or Rehabilitation
Team Coodinator

Date

Appendix G
SAMM Program Study Consent Form
(Control Group)
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LOMA LINDA UNIVERSITY MEDICAL CENTER
S.A.M.M. Program Study
Consent Form
I am willing to participate in a study to be conducted at the Loma Linda
University Medical Center.
I have been told that:
1.

the study is designed to help health care personnel understand
the effect of medication teaching on patients.

2,

during the course of the study, I will be expected to undergo
periodic testing to check my knowledge, attitudes and health
behavior related to my illness.

3.

a respiratory home care therapist will visit my home monthly
for 6 monts to administer these tests.

4.

I will be informed of change in the nature of the study or in
the procedures described above.

5,

the study involves no financial cost to me. There may be a
potential risk of fatigue as a result of taking written tests
that measure my knolwedge and health behaviors. I have been
told that these tests will have general and personal questions.

6,

the benefits of being involved in this study is that I will re
ceive a free supply of any oral Theodur prescribed for me during
the length of the study.

7.

if at any time in this study it is determined that my assigned
medication program is found to be less beneficial than another,
I will be promptly notified.

8.

refusal to participate in this study will involve no penalties
or loss of benefits to which I am entitled. I have been told
that the information obtained in this study is confidential and
that my name and identity will not be disclosed without my
consent in any published document,

9.

my participation in this study is voluntary and I may leave
the study at any time unconditionally and without prejudice to
my continued care.
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10.

in the event of difficulties as a result of participation in
the research program, I may contact Glenn Sharman, Patient Rep
resentative at (714) 824-0800, extension 4634, for information.

I have read the contents of this consent form and have listened to the
verbal explanation of the investigator. My questions concerning this
study have been answered to my satisfaction. I may call Elizabeth Maddox,
RN, researcher, at the Pulmonary Rehabilitation Department (714)824-4495
if I have additional questions or concern about my participation in this
study, I have been given a copy of this consent form.

Signature of Subject

Date

Witness
I have reviewed the contents of this form with the person signing above.
I have explained potential risks and benefits of the study, as described
above.

Investigator

Date

For all inpatient studies, to insure that patients receive coordinated
care from the investigator and the primary physician or rehabilitation
team, the primary physician or rehabilitation team coordinator must sign
this form as indicating he/she has knowledge of this research study.

Signature of Primary Physician or Rehabilitation
Team Coodinator

Date

Appendix H
Data Collection Form
Initial Assessment
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Data Collection Form
Initial Assessment

Date:
Name:
Address:
Physician:
Patient number:
Age:
Pulmonary diagnosis:
Speaks English?:
Alert and Oriented?:
Ever in the SAMM Program?:
Other related disease processes:
Is patient medically stable?:
(per primary physician)

Source of Income:
Present Medications:

Date

Appendix I
Data Collection Form
Hospital Discharge Assessment

51

52

Data Collection Form
Hospital Discharge Assessment

Date:
Patient number:
Physician:
Further medical problems?:

Alert and oriented?:
Present medications:
Blood theophylline level:
Pill count (# bronchodilator pills
sent home):
Knowledge test given?:

Appendix 0
Data Collection Form
Monthly Home Assessment
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Data Collection Form
Monthly Home Assessment
Date:
Patient number:
Physician:
Alert and oriented?:

Further medical problems?:

List

Change in source of income?:

How?

Ask subject:
1.

How frequently have you been taking your Theodur?
Response_________________________________________

2.

At what dosage have you been taking the Theodur?
Res ponse_____________________________________

3.

Have you missed any doses?

4.

If so, approximately how many pills have you missed
over an average week? Response_________________

5.

Do you feel you have been able to take your medication
as prescribed? Response_______________________

6.

If not, why not?

Response____________

Response

Theophylline level (3 & 6 month only):

Month:

Pill count:
# supplied last visit
# remaining in container this visit
# supplied at this visit
Knowledge test given?

(3 & 5 month only):

Month:

Appendix K
Pulmonary Medication Knowledge Test
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Pulmonary Medication Knowledge Test
Please circle the letter beside the correct answer of each question:
Multiple Choice
1 .

A bronchodi1ator medication is to
a,
b,
c,

2.

The name of my bronchodila tor is
a,
b.
c.
d,

3.

b.
c.

d.

rapid heart beat
headache
sleeplessness
wheezing

If I become dizzy from my bronchodi1ator medication I should
a.
b.
c.
d.

6.

shakiness, nervousness
backache
sores in the mouth
I don't know

Other side effects of bronchodi1ator medications might include
(pick any/all answers that apply)
a.
b.
c.
d.

5.

Theodur
Choledyl
Bre thine
I don 11 know

Bronchodi1ator medications can cause

a.

4.

heal my lungs
open airways
I don't know

change my dose
stop taking my medicine until I see my doctor again
call my doctor's office for instruction
I don't know

If a pharmacist fills your prescription, and the name is different
from what you remember, you should first:
a.
b,
c,
d.

remember the pharmacist knows what he is doing and forget it
ask the pharmacist for clarification
realize he may have given you a generic name on the label, and
go ahead and take it
I don't know
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7.

8.

9.

The main job of the lungs is
a.
b.

to exchange oxygen for carbon dioxide
to clean the air coming in

c.

I don't know

The following things help protect the lungs from irritants
a.
b.

air sacs, trachea, capillaries
coughing, cilia and macrophages

c.

I don't know

Mucus
a.

10.

b.

should always be totally eliminated as it can cause infect
ions
is a part of the lung's defense system

c.

I don’t know

When wheezing starts
a.

I should call my doctor immediately and then go to an
emergency room
b. first find a quiet place and use pursed lip breathing
c. I don't know

True and False:

circle T if the statement is true and F if it is false

11.

If a bronchodilator medicine does not work in 30 minutes I
should take another smaller dose. T or F?

12.

Over-the-counter medicines can be used without consulting my
physician. T or F?

13.

If I forget my bronchodilator medicine, and a friend has another
one that is similar, I can take it instead just this once.

T or F?
14.

If a dose of bronchodilator medicine is missed and the next dose
is in 4 hours, I whould go ahead and take the missed dose.

T or F?
15,

When traveling, a good idea is to put one day's supply of all
my different pills together in a smaller container. T or F?

16.

Each medicine has two names -- a brand name and generic name.
Generic medicines are usually less expensive than brand name
types. T or F?
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17.

If I am taking several types of medicine, it is a good idea
for me to go to the same pharmacist, who can check on possible
problems with drug interactions. I or F?

18.

I should always take my medicines with me when I go to a hospi
tal emergency room. T or F?

19.,

It is my doctor's job to worry about my medicines, I just take
them, I or F?

20.

If I get very short of breath in the night I should immediately
call the paramedics. T or F?

